Log in to save to my catalogue

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8463343

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

About this item

Full title

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

Author / Creator

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2021-07, Vol.81 (11), p.1331-1342

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Netupitant/palonosetron (NEPA; Akynzeo
®
), available in oral and intravenous (IV) formulations, is a fixed-dose combination of the neurokinin 1 (NK1) receptor antagonist netupitant (or the prodrug, fosnetupitant, in the IV formulation) and the second-generation serotonin 3 (5-HT
3
) receptor antagonist palonosetron. Administered as a s...

Alternative Titles

Full title

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8463343

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8463343

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.1007/s40265-021-01558-2

How to access this item